Trial no.:
|
PACTR202309863209397 |
Date of Approval:
|
13/09/2023 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effect of normal saline ice packs on blood loss after delivery: A randomized clinical trial. |
Official scientific title |
Effect of normal saline ice packs on blood loss after delivery: A randomized clinical trial. |
Brief summary describing the background
and objectives of the trial
|
Obstetric hemorrhage is the commonest single cause of maternal mortality worldwide. Without timely and appropriate treatment, postpartum hemorrhage (PPH) may ensue and lead to disseminated intravascular coagulation, hemorrhagic shock, multiple organ failure, and even death. Hemorrhage is very common in both urgent and elective cesarean sections (CS) and often requires B-lynch suture, uterine artery ligation, transcatheter arterial embolization, and even hysterectomy to stop bleeding. However, these approaches are rather difficult to carry out, especially in resource-poor settings. Another choice is intrauterine packing, which stops bleeding to some extent using compression power and is used effectively in resource poor settings. However, this technique may affect the suture of the uterine incision and cause infection. Iced saline solution has been used to treat gastric lavage in gastroduodenal hemorrhage caused by peptic ulcer and erosive gastritis and has been shown to be effective for control of active hemorrhage. The constant cold stimulation on the myometrium causes muscles to shrink, introducing the homeostasis effect. Also, a cold compress can cause local blood flow to decrease, during the process of which coagulation is facilitated as local blood flow slows down, blood thickens and platelets aggregate. This raised the assumption that application of ice packs on the uterus after delivery would be associated with decreased blood loss.
Primary objective:
To evaluate the amount of blood loss between women who applied ice packs and those who did not.
Secondary objective:
To determine the prevalence of PPH among both groups. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
10/09/2023 |
Actual trial start date |
15/09/2023 |
Anticipated date of last follow up |
10/03/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
46 |
Actual target sample size (number of participants) |
|
Recruitment status |
Active, not recruiting |
Publication URL |
|
|